Showing 17–26 of 26 results
NAD⁺ is a naturally occurring coenzyme involved in cellular redox reactions and metabolic pathways. It has gained attention within the scientific community for its potential role in preclinical research models focused on cellular energy regulation, enzymatic activity, and intracellular signaling mechanisms.
PT-141, also known as Bremelanotide, is a synthetic peptide studied in preclinical research for its interaction with melanocortin receptors and its role in central signaling pathways. This peptide has gained attention within the scientific community for its potential applications in laboratory models focused on neuropeptide signaling, receptor activation, and behavioral response mechanisms.
Selank is a synthetic peptide studied in preclinical research for its potential role in neurochemical signaling and receptor-mediated regulatory processes within the central nervous system. It has gained attention within the scientific community for its application in laboratory models focused on neurotransmitter-related signaling, peptide-receptor interactions, and cellular communication pathways.
Semax is a synthetic peptide studied in preclinical research for its potential role in neurochemical signaling and cognitive pathway modulation. It has gained attention within the scientific community for its application in laboratory models focused on neurotransmitter regulation, neurotrophic activity, and brain-derived signaling
SS-31 is a synthetic mitochondria-targeting peptide studied in preclinical research for its potential role in mitochondrial function, cellular bioenergetics, and oxidative stress pathways. It has attracted scientific interest for its application in laboratory models investigating mitochondrial health, energy production, and cellular signaling mechanisms.
TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4, studied in preclinical research for its role in cellular migration, cytoskeletal organization, and tissue-related signaling pathways. This peptide has gained attention within the scientific community for its potential applications in laboratory models focused on cell differentiation, angiogenesis, and regenerative processes.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), studied in preclinical research for its role in endocrine signaling and hormone regulatory pathways. This peptide has attracted attention within the scientific community for its potential applications in laboratory models focused on growth hormone dynamics, metabolic signaling, and receptor-mediated cellular communication.
In laboratory settings, GHK-Cu has been studied for its interaction with pathways associated with extracellular matrix remodeling, cellular differentiation, and copper transport mechanisms. Researchers have explored its stability and its potential influence on processes related to cellular maintenance and structural protein activity under controlled experimental conditions.
Ipamorelin and CJC-1295 are synthetic peptides studied in preclinical research for their complementary roles in growth hormone signaling and receptor-mediated pathways. This combined formulation has gained attention within the scientific community for its potential application in laboratory models examining endocrine signaling, cellular communication, and hormone-related regulatory pathways.
JMP-2 (Tirz) is a synthetic peptide studied in preclinical research for its potential role in modulating cellular signaling pathways related to gastrointestinal tissue